Echinocandin Adaptation in <i>Candida albicans</i> Is Accompanied by Altered Chromatin Accessibility at Gene Promoters and by Cell Wall Remodeling
Infections by the major opportunistic pathogen of human <i>Candida albicans</i> are commonly treated with echinocandin (ECN) drugs. However, <i>C. albicans</i> can adapt to grow in the presence of certain amounts of ECNs. Prior studies by several laboratories have defined mul...
Saved in:
| Main Authors: | Sudisht K. Sah, Anshuman Yadav, Tyler Stahl, Jeffrey J. Hayes, Michael Bulger, Elena Rustchenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Journal of Fungi |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2309-608X/11/2/110 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tn-seq screens in Candida glabrata treated with echinocandins and ibrexafungerp reveal pathways of antifungal resistance and cross-resistance
by: Timothy J. Nickels, et al.
Published: (2025-07-01) -
Tolerance and heteroresistance to echinocandins in Candida auris: conceptual issues, clinical implications, and outstanding questions
by: Erika Shor, et al.
Published: (2025-05-01) -
Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
by: Yating Ning, et al.
Published: (2023-12-01) -
Microbial Interactions in Nature: The Impact of Gram-Negative Bacilli on the Hyphal Growth of <i>Candida albicans</i>
by: Madalina Adriana Bordea, et al.
Published: (2025-03-01) -
<i>Candida glabrata</i> Prosthetic Joint Infection Managed with Ibrexafungerp
by: Ella Nadarevic, et al.
Published: (2025-06-01)